Fig 2: Expression of integrin avß6, tissue factor, PARP-1, uPAR, VEGFR1, EpCAM, VEGFR2, Cathepsin E and integrin avß3 in primary tumor tissue of OSCC.

Fig 3: Expression of CK5 (for visualization of tumor localization), uPAR, integrin avß6 and tissue factor in (A) primary tumor, (B) lymph node metastases, and (C) local recurrence.

Fig 4: Hyperforin affects the expression of proteins involved in tumor invasion and metastatic potential. Cell were transfected with either HMOX-1 siRNA or a scrambled siRNA. After 24 h of transfection, the cells were treated with or without 3 µM of HPF. Representative immunoblots show the expression level of CD133 antigen, octamer-4 (OCT-4), tyrosine-protein kinase receptor UFO (AXL), urokinase plasminogen activator receptor (uPAR), metalloproteinase-2 (MMP-2), and GAPDH as a loading control. The histograms represent the mean values ± S.D. of protein expression levels, which were measured via densitometry and derived from three independent experiments. Statistical comparisons were conducted using Student’s t-test for unpaired samples after data normalization with GAPDH expression. * p < 0.05; ** p < 0.01; *** p < 0.001.

Fig 5: Correlation between SUVmax and the immunohistochemical uPAR expression expressed as the product of H-score and tumor depth in 17 primary tumors.